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Strategies for the design of minor groove binders: 
a re-evaluation based on the emergence of 
site-selective carbohydrate binders 
Studies on minor groove binders provide new insights into DNA structure and 
recognition, information that may in the future serve as the basis for the 
design of synthetic binders targeted to particular minor groove sites. 
Carbohydrate-based minor groove binders are emerging as a 
particularly interesting and important class of 
ligands for DNA. 
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Small molecules that bind in the minor groove of DNA 
frequently have cytotoxic activity because they interfere 
with the binding of proteins necessary for DNA replica- 
tion and transcription. Some of these small molecules 
have proven very useful as antitumor agents because they 
selectively kill rapidly-dividing cells. This has stimulated 
efforts to design molecules that bind at designated sites 
in the minor groove. It is believed that groove binders 
with increased selectivity will produce a greater biologi- 
cal response for a given dose (and hence cause fewer 
toxic side effects) than non-selective groove binders [l]. 
Molecules that target particular DNA sites also have the 
potential to be used for the selective suppression of trans- 
cription from particular gene sequences [2,3]. But to 
design sequence-selective minor groove binders, one 
needs to know how the structures of various minor 
groove sites differ and how molecules sense these differ- 
ences. Studies on existing minor groove binders, both 
small molecules and proteins, are leading to a better 
understanding of possible strategies for sequence-selec- 
tive groove binding. Below I evaluate current views of 
the minor groove and then discuss how carbohydrate- 
based DNA binders, which are emerging as an important 
class of minor groove binders, fit into the picture for 
DNA recognition and new ligand design. 
The evolving view of the minor groove 
For many years the major groove was the focus of most 
studies aimed at understanding sequence-specific DNA 
recognition. This emphasis grew largely out of the belief 
that complementary networks of hydrogen bonds 
provide the primary basis for specific DNA recognition. 
There are more hydrogen bond donors and acceptors 
on the major groove edge of each base pair than on the 
minor groove edge.There are, therefore, more opportu- 
nities for discriminating different base pairs using hydro- 
gen bonds from the major groove. In the minor groove, 
the principal difference between base pairs is that G-C 
Fig. 1. Functionality in the minor 
groove at (a) A-T and (b) G-C base 
pairs. The exocyclic NH, group of the 
guanidinium protrudes into the minor 
groove (red outline, lower diagram). 
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base pairs contain an exocyclic amino group that pro- 
trudes into the groove. This amino group makes the 
steric and electronic environment of the minor groove 
at G-C base pairs profoundly different from that at A-T 
base pairs (Fig. 1). Thus, while designing ligands to dis- 
criminate A-T-rich and G-C-rich DNA sites in the 
minor groove seemed feasible, the potential for achiev- 
ing greater sequence discrimination was regarded by 
many as limited [4]. 
This picture of the potential for sequence-selective 
binding in the minor groove has changed considerably in 
the past few years because of several developments. In 
1989, Wemmer and colleagues [5] showed that dis- 
tamycin, the prototypical A-T selective minor groove 
binder, can bind to DNA as an antiparallel dimer. This 
unexpected finding forced a re-evaluation of the nature 
ofA-T selectivity and the role of a narrow minor groove 
in binding site selection. More importantly, the finding 
raised new possibilities for the design of minor groove 
binders that are selective for sequences containing mixed 
A-T and G-C base pairs, or for sequences containing 
only G-C base pairs, using a hydrogen bonding strategy 
(see below). 
Attitudes towards minor groove recognition have also 
changed as more structural information about 
protein-DNA recognition has accumulated and ideas 
about how selectivity can be achieved have expanded to 
include mechanisms other than complementary arrays 
of hydrogen bonds. For example, sequence-dependent 
DNA flexibility, or the ability of particular runs of base 
pairs to distort to provide a complementary binding 
surface for proteins or other ligands, can provide a high 
degree of binding selectivity without the formation of 
specific arrays of hydrogen bonds. In a striking example 
of this, the crystal structure of a minor groove TATA 
box-binding protein (TBP) shows that it induces severe 
bending of the TATA box and widening of the minor 
groove [6]. There are only five protein-base hydrogen 
bonds in the complex, leaving unsatisfied thirteen of 
seventeen possible hydrogen bond acceptors on the 
minor groove edges of the bases. Binding selectivity is 
apparently achieved largely through an induced tit. 
Finally, carbohydrate-based DNA binders that defy old 
paradigms for minor groove recognition have recently 
been identified. These molecules are also helping to 
change perceptions about how much selectivity is possi- 
ble in minor groove binding and how that selectivity 
can be achieved. 
Carbohydrate-based minor groove binders 
DNA binders that contain carbohydrates have been 
known for over thirty years. For most of that time, 
however, the carbohydrate portions of DNA-binding 
glycoconjugates were believed to contribute little to the 
selectivity that the molecules displayed. That view 
changed rapidly with the discovery of the enediyne anti- 
tumor antibiotic calicheamicin. Calicheamicin consists of 
a bicyclic enediyne moiety attached to a tetrasaccharide- 
aryl tail (Fig. 2). Under reducing conditions, the enediyne 
rearranges to produce a 1,4-aryl diradical, which abstracts 
hydrogen atoms from the DNA backbone initiating 
DNA strand scission. Studies on the cleavage selectivity of 
calicheamicin showed that it displays a new kind of speci- 
ficity It is neither A-T selective nor G-C selective [7]. 
Instead, it seems to bind to a variety of sites containing 
three or more pyrimidines in a row.The steric and elec- 
tronic environments of many of the sites appear to be 
very different because some contain guanine amino 
groups and some do not [7,8]. Any mechanism for 
achieving binding selectivity must be able to explain 
calicheamicin’s affinity for sites which present very differ- 
ent functionality. Investigations from several laboratories 
have shown that the carbohydrate portion of caliche- 
amicin is the principal DNA-binding element and is 
largely responsible for the oligopyrimidine selectivity 
[9-l 11. Based on an analysis of different pyrimidine-rich 
binding sites, we proposed that the binding selectivity 
involves an induced fit process [8]. 
The first structural evidence for an induced fit recogni- 
tion process came from circular dichroism measurements 
by Sugiura and coworkers [12] and NMR experiments 
in our laboratories [13]. Our NMR studies showed that 
calicheamicin binds in the minor groove with the 
oligosaccharide tail contacting the bases in the recogni- 
tion sequence (Fig. 3).The oligosaccharide curves gently 
to follow the winding path of the minor groove. The 




Fig. 2. Structure of calicheamicin y,r and diradical intermediate involved in DNA damage. The ten-membered benzenoid system of the 
enediyne core is shown in red. Cleavage of the allylic trisulfide followed by conjugate addition of the resulting thiolate to the bridge- 
head double bond triggers the cyclization to form the diradical, which can attack DNA, initiating cleavage.Elements A-E of the 
oligosaccharide tail are labelled. 
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Fig. 3. Two views of calicheamicin 
bound ir I the minor groove of DNA. The 
front vif :w (top) shows calicheamicin 
tracking along the minor groove. The 
side vie\ N (bottom) shows which func- 
tional go roups on calicheamicin point 
towards the floor of the groove and 
which pc Jint out towards the solvent. 
N-O bond in calicheamicin, which enforces an unusual 
conformation between the A and B sugars and allows 
the carbohydrate tail to track along the minor groove 
[13-151. The position of the oligosaccharide with 
respect to the recognition sequence is essentially identi- 
cal regardless of whether the sequence recognized is 
ACCT [13], TTTT [16], or TCCT [17]. The similar 
positioning is further evidence that oligopyrimidine 
sequences have some structural features in common that 
calicheamicin is able to sense. These structural features 
are not common hydrogen bonding arrays. Although 
one typically thinks of oligosaccharides as heavily 
hydroxylated molecules with a large number of potential 
hydrogen bond donors and acceptors, the calicheamicin 
oligosaccharide is unusually hydrophobic and contains 
only a small number of hydrogen-bonding partners. Of 
these, most do not contact the bases in the floor of the 
minor groove, but instead are directed towards the 
ribose-phosphate backbone. These hydrogen bonds 
appear to function primarily to anchor the molecule in 
the groove. In any event, there are no electrostatic con- 
tacts between calicheamicin and the floor of the groove 
which are common to all the different recognition 
sequences. Instead, changes observed in some of the 
DNA helix parameters upon binding calicheamicin 
(including an increase in groove.width and changes in 
the conformation of some of the ribose sugars) indicate 
that pyrimidine sequences may share an ability to distort 
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readily to accommodate the drug. The distortion is 
much less dramatic than that produced by TATA 
binding proteins, but may be sufficient to explain the 
energetic differences that lead to specificity of binding. 
There are a large number of other DNA binders that 
contain sugars as components, although in many cases 
the role of the sugars is still unclear. Calicheamicin is the 
first example of a DNA-binding molecule in which the 
carbohydrate portion itself binds site-selectively to DNA 
[9,10], but several examples are known in which the 
carbohydrates are essential for binding ([18], and refer- 
ences therein). A comparison of calicheamicin with 
these other DNA-binding glycoconjugates reveals simil- 
arities in the structures of the carbohydrates that may 
prove useful in design. For example, like the calicheam- 
icin oligosaccharide, the carbohydrates in the aureolic 
acid antibiotics are quite hydrophobic [19]. Many of the 
sugars are 2,6-dideoxy sugars. Of the remaining hydrox- 
yls, many are alkylated or acylated (Fig. 4). The 
hydrophobicity of the sugars is probably significant in 
helping to drive the binding [20]. The hydrophobicity 
makes DNA-binding sugars very different from the 
hydrophilic cell-surface carbohydrates involved in 
protein recognition. Other minor groove binding glyco- 
conjugates such as chromomycin A, also distort DNA 
upon binding [21] (Fig. 4). Hence, sequence-dependent 
DNA flexibility may be significant in the site-selectivity 
displayed by many carbohydrate-containing minor 
groove binders. The relative rigidity of carbohydrates 
may be important in forcing the DNA to adapt to the 
shape of the carbohydrate molecule. 
Strategies for the design of new minor groove binders 
One of the most effective strategies for the design of 
site-selective minor groove binders is to construct 
derivatives of the netropsin/distamycin class of minor 
groove binders ,in which some of the individual pyrrole 
rings are replaced by other structures (such as imidazole 
or pyridine) intended to impart selectivity for G-C 
base pairs [22, 231. The idea is to use a known minor 
groove binding scaffold but to modify it to include 
Fig. 4. Structure of chromomycin A,, a member of the aureolic acid 
class of DNA-binding molecules. Many of the OH groups on the 
sugars on this class of molecules are either alkylated or acylated. 
hydrogen-bond acceptors that can contact the amino 
groups in the minor groove at G-C base pairs [24].The 
first efforts to implement this strategy were unsuccessful 
in the sense that they produced binders with unantici- 
pated selectivity that could not easily be rationalized 
[23]. Wemmer’s finding that distamycin can bind to 
DNA as an antiparallel dimer [5] provided the clue that 
allowed others to interpret the results of some of their 
efforts to make G-C-selective binders by modifying the 
distamycin/netropsin framework. For example, Dervan’s 
efforts to design ligands that recognize DNA sequences 
including G-C base pairs suddenly made sense if the 
ligands were assumed to bind to DNA as dimers [25]. 
Since Wemmer’s report in 1989 [5], the laboratories of 
both Dervan [26] and Lown [27] have made a number 
of modified ligands based on the distamycin/netropsin 
motif that bind as antiparallel dimers at designated 
sequences in the minor groove of DNA. In a particu- 
larly dramatic result, Dervan, Wemmer and coworkers 
[28] designed d h an c aracterized a molecule that binds 
as a dimer to the sequence 5’-(A,T)GCGC(A,T)-3’. 
The specificity is due largely to a network of hydrogen 
bonds between each ligand and each strand of the 
DNA.Thus, now that a scaffold has been identified that 
provides for enough hydrogen bonding contacts to each 
base pair to allow for better discrimination [4], it 
appears to be possible to design selective minor groove 
binders targeted to a wide range of different DNA 
sequences, including mixed sequences and G-C 
sequences, using patterns of hydrogen bonds. 
The carbohydrate-containing minor groove binders 
suggest another strategy for design. An induced fit 
process has a large role in the site-selective binding of 
both calicheamicin and the aureolic acid antibiotics such 
as chromomycin, mithramycin and olivomycin to the 
minor groove of DNA, and one might envision a design 
strategy focused on exploiting sequence-dependent 
DNA flexibility. The difficulty in implementing such a 
strategy is two-fold: first, the relationship between DNA 
sequence and the ability to undergo particular deform- 
ations is not currently well understood, and, second, even 
if more were known about which types of sequences 
share an ability to deform in a similar manner, designing 
ligands de nova to exploit this flexibility would be diffi- 
cult. But just as the netropsin/distamycin class of anti- 
biotics provided the starting point for implementing a 
design strategy emphasizing hydrogen bonds, caliche- 
amicin and the other carbohydrate-containing DNA 
binders provide blueprints for the design of ligands that 
sense DNA flexibility. 
Studies on calicheamicin have suggested that pyrimidine- 
rich sequences share an ability to adapt their conform- 
ation in a particular way. Starting with scaffolds related to 
calicheamicin, it may be possible to design other 
oligopyrimidine-selective binders and thereby learn 
more about what is important in determining the selec- 
tivity for drug binding. The structural work on 
calicheamicin suggests that the shape of the molecule, 
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which is primarily determined by the conformation of 
the linkages between sugars, is critical in determining its 
selectivity of binding. It may be possible to design 
simplified ligands that have similar shapes to caliche- 
amicin by preserving the glycosidic linkages while alter- 
ing the individual sugars so that they are easier to 
produce. In a similar manner, it should be possible to use 
chromomycin and other aureolic acid antibiotics as blue- 
prints for designing glycoconjugates that are G-C-selec- 
tive binders, thereby clarif+ng the contributions of 
induced fit and hydrogen bonding to selectivity. Again, 
by determining which features are critical for binding 
and which are not, it may be possible to design radically 
simplified systems [29:1. Ultimately, these simplified 
systems may provide a ‘starting point for the design of 
ligands with altered or increased selectivity. 
Conclusion 
Site-selective minor groove binding ligands have a 
number of important uses. Above I have described two 
strategies for the design of new minor groove binding 
ligands based on existing scaffolds. One strategy empha- 
sizes the role of hydrogen bonding in determining select- 
ivity. By designing molecules with hydrogen bonding 
partners complementary to particular sequences, it is 
possible to achieve a high degree of selectivity in minor 
groove binding. 
The second strategy emphasizes induced fit as a mecha- 
nism for achieving selectivity. Relatively rigid ligands 
which force the DNA to mold around them can bind 
quite selectively as they exploit differences in DNA flex- 
ibility at different sequences. It is not yet known if the 
same degree of binding selectivity can be achieved using 
this strategy as using a hydrogen-bonding strategy. 
Nevertheless, this strategy may have some advantages that 
a ‘pure’ hydrogen bonding strategy does not have. For 
example, it has been shown that both mithramycin and 
the calicheamicin oligosaccharide can displace transcrip- 
tion factors that bind in the major groove [2,3].The dis- 
placement is presumably related to the effects that these 
minor groove binders have on DNA structure. In 
contrast, binding of netropsin in the minor groove is 
compatible with the binding of at least some transcrip- 
tion factors in the major groove [30]. (Netropsin is very 
effective at preventing the binding of the general tran- 
scription factor TATA box binding protein, which binds 
in the minor groove [31].) These findings suggest that in 
order to disrupt transcription of a particular gene with a 
minor groove binder, one wants a molecule that is selec- 
tive for the regulatory region in question and that affects 
the DNA conformation in a way that prevents binding 
of the necessary transcription factors. Ultimately, of 
course, this goal will probably be best met by developing 
hybrid approaches to the design of minor groove ligands 
in which both sequence-dependent DNA flexibility and 
hydrogen bonding have a role in determining the pre- 
ferred sites (as they are thought to do in the case of the 
aureolic acid antibiotics). The work that is currently 
being done to understand existing minor groove binders 
will lay the groundwork for more sophisticated strategies 
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